What You Should Know
Nordic Global has released 2026 survey findings showing that 61% of healthcare IT leaders now view Application Managed Services (AMS) as a central, rather than supplemental, part of their IT strategy.The market is seeing a distinct urban-rural divide: 70% of urban organizations view AMS as a strategic lever for transformation, compared to 43% of rural organizations who use it primarily for operational resilience.Urban and large health systems are increasingly using AMS to
Read More
Aidoc Secures $150M to Accelerate Enterprise-Scale Clinical AI Across 2,000 Hospitals
What You Should Know
Aidoc has raised $150M in Series E funding, led by Growth Equity at Goldman Sachs Alternatives, bringing its total funding to over $500M. The round included participation from General Catalyst, SoftBank Investment Advisors, and NVentures (NVIDIA's venture capital arm).Capital will be used to further develop Aidoc's CARE™ clinical foundation model and its aiOS™ enterprise platform.The company currently analyzes more than 60 million patient cases annually and is deployed
Read More
Operationalizing Precision Medicine 2026: U.S. Health Systems Scale Genetic Testing and AI Integration
What You Should Know
Precision medicine has transitioned from "one-off" testing to organized institutional programs at more than three-quarters of surveyed U.S. health systems, according to new research from the Center for Connected Medicine (CCM) at UPMC.This represents a massive shift from 2020, when 69% of organizations had little to no precision medicine deployment.While adoption is high, reimbursement uncertainty, high costs, and operational complexity remain the primary barriers to
Read More
CareDx to Acquire Naveris for $160M to Expand into HPV-Driven Cancer MRD Monitoring
What You Should Know
CareDx has entered into a definitive agreement to acquire Naveris, a precision oncology company specializing in blood-based monitoring for viral-mediated cancers.The deal includes $160M in up-front cash, with potential for an additional $100M based on future revenue milestones.Naveris’ flagship platform utilizes Tumor Tissue Modified Viral (TTMV®) DNA to detect and monitor HPV-driven cancers with high accuracy.The acquisition is expected to close in the third quarter of
Read More
Rad AI Appoints David Leonard as COO and Elizabeth Bergey, MD, as First Chief Clinical Officer
What You Should Know
Rad AI has appointed David Leonard as Chief Operating Officer (COO) and Elizabeth Bergey, MD, as the company’s first Chief Clinical Officer (CCO).Leonard, previously Head of Operations, Strategy, and Investor Relations, will focus on scaling internal infrastructure and enhancing go-to-market strategies for AI-enabled reporting.Dr. Bergey, a board-certified radiologist and former CEO of Quantum Radiology, transitions from Chief Medical Innovation Officer to lead clinical
Read More
Weave Bio Launches AI-Native NDA Submission Support in Strategic Partnership with Parexel
What You Should Know
Weave Bio has expanded its AI-native regulatory platform to support New Drug Application (NDA) submissions, covering the full drug development lifecycle.Strategic partner Parexel co-developed and refined the platform, resulting in authoring speeds that are 60% faster than traditional manual methods.The platform utilizes AI-native data extraction, content verification, and automated authoring to synthesize clinical, non-clinical, and manufacturing data.Parexel will
Read More
Moderna Deploys Salesforce Agentforce Life Sciences to Unify Global Commercial Operations
What You Should Know
Moderna has selected Salesforce’s Agentforce Life Sciences to serve as its unified, global platform for commercial operations and customer engagement.The platform will consolidate data from SAP, ecommerce, and regional systems to create a single "Customer 360" source of truth for all healthcare provider (HCP) interactions.Field teams will utilize AI-powered agents to automate cycle planning, deliver "next best action" recommendations, and streamline real-time call
Read More
FDA Announces Real-Time Clinical Trial Pilot Program and Proof-of-Concept Studies with AstraZeneca and Amgen
What You Should Know
The FDA has launched two proof-of-concept (PoC) real-time clinical trials (RTCT) that report endpoints and data signals to the agency as they occur.AstraZeneca is leading a Phase 2 trial (TRAVERSE) for mantle cell lymphoma, while Amgen is conducting a Phase 1b trial (STREAM-SCLC) for small cell lung carcinoma.The initiative aims to eliminate the traditional "hiatus" between clinical phases, moving toward a model of "continuous" trials that reduces regulatory lag.A Request
Read More
Beth Israel Lahey Health Partners with Heidi to Deploy Ambient AI Scribing to All Physicians
What You Should Know
Beth Israel Lahey Health (BILH) is expanding its partnership with Heidi to provide ambient AI scribing capabilities to all of its more than 6,000 providers.An initial 6-month trial involving 1,000 providers resulted in 89% satisfaction regarding the quality of generated medical notes.The technology significantly impacts clinician well-being, with 82% of trial users reporting reduced cognitive load and 74% noting a reduction in time spent working outside of standard
Read More
Koda Health Secures Investment from UPMC Enterprises for AI-Enhanced Advance Care Planning Platform
What You Should Know
The Investment: Koda Health secured a Series A strategic investment from UPMC Enterprises to aggressively scale its AI-enhanced Advance Care Planning (ACP) platform across complex patient populations.The Financial Toll: The American healthcare system currently spends an estimated $200 billion annually on care that patients would not have wanted had they been engaged in care planning earlier in their journey.The Technology Engine: The platform navigates patients through
Read More
